Barbara A. Santevecchi

Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae

Barbara A. Santevecchi, Tiffeny T. Smith, Shawn H. MacVane · International Journal of Antimicrobial Agents · 2018 · 31 citations

Antibiotic-resistant Organisms, Antimicrobial Susceptibility, Health Sciences +12

In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates

Jeanne Forrester, Lisa L. Steed, Barbara A. Santevecchi et al. · Open Forum Infectious Diseases · 2018 · 22 citations · Full text

Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center

Veena Venugopalan, Malva Hamza, Barbara A. Santevecchi et al. · American Journal of Health-System Pharmacy · 2022 · 15 citations

Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase–producing Enterobacterales bloodstream infections (REDUCE-BSI)

Catherine Vu, Veena Venugopalan, Barbara A. Santevecchi et al. · Antimicrobial Stewardship & Healthcare Epidemiology · 2022 · 13 citations · Full text

Impact of Empiric Linezolid for Necrotizing Soft Tissue Infections on Duration of Methicillin-Resistant <i>Staphylococcus aureus</i> -Active Therapy

Alexandra Lehman, Barbara A. Santevecchi, Kelly Maguigan et al. · Surgical Infections · 2022 · 11 citations